Safe and Effective Medicines for Children

Author : Board on Health Sciences Policy,Thomas F. Boat

Paperback

Published : Saturday 13 October 2012

ISBN : 9780309225496

Price : €62.01

Description

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

You may also like ...

Safe and Effective Medicines for Childr...

by Board on Health Sciences Policy,Thomas F. Boat

Paperback

13 Oct 2012

Paediatric medicine

€62.01

Extended stock – Dispatch 5-7 days

Rare Diseases and Orphan Products

by Board on Health Sciences Policy,Thomas F. Boat

Paperback

03 Apr 2011

Diseases and disorders

€43.29

Extended stock – Dispatch 5-7 days

Advancing Regulatory Science for Medica...

by Board on Health Sciences Policy,Theresa Wizemann

Paperback

27 Aug 2011

Health systems and services

€44.46

Extended stock – Dispatch 5-7 days

Glutamate-Related Biomarkers in Drug De...

by Board on Health Sciences Policy,Miriam Davis

Paperback

05 Aug 2011

Neurology and clinical neurophysiology

€21.05

Extended stock – Dispatch 5-7 days

Reviews